Nj State Employees Deferred Compensation Plan Amgen Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Amgen Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 8,000 shares of AMGN stock, worth $2.49 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
8,000
Previous 8,000
-0.0%
Holding current value
$2.49 Million
Previous $2.58 Million
19.09%
% of portfolio
0.26%
Previous 0.31%
Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
3,188Shares Held
418MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.4 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.17 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.54 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.11 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $167B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...